Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)

This study used an external endocardial acceleration sensor (sonR sensor), placed on the patient's chest, to time the closure of aortic and mitral valves, and compared its performance with echocardiography.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Congestive Heart Failure Cardiovascular Diseases Heart Diseases Heart Failure

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Nouvelles Cliniques Nantaises, Nantes, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Every patient coming in the participating centers for an echocardiographic exam and implanted with a pacemaker or an implantable cardioverter defibrillator (ICD) can be included in the study.

Exclusion criteria

Inability to understand the patient information sheet.
Minor patient or pregnant woman.

Treatment and study plan

Echocardiography and SonR recording

Other

Primary outcomes

The timings of mitral (tMC) and aortic (tAC) valves closure by echocardiography and sonR

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

LivaNova

Industry

Registry information

Official study title

Echocardiography and PEA Measurements in CRT Therapy

Important dates

Study start: 2007
Primary completion: 2009
Study completion: 2009
First posted: Feb 10, 2010
Registry last updated: Mar 5, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed